HEIA:EURONEXT AMSTERDAMHeineken NV Analysis
Data as of 2026-03-10 - not real-time
CA$9.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at ~9.9 CAD, comfortably below its 20‑day SMA of 10.79 and the identified support level of 10.29. This price gap signals a technical pull‑back despite a broader bullish trend indicated by SMA20 > SMA50 > SMA200. Momentum is extreme, with the RSI perched at 81.8, flagging overbought conditions. The MACD histogram is negative and the signal line is bearish, confirming short‑term downside pressure. Volatility remains elevated at over 26% on a 30‑day basis, while average volumes have been dwindling, pointing to a liquidity squeeze. Fundamentally, the company reports a trailing PE of only 1.87 and a DCF‑derived fair value near 2.42, suggesting the market price is materially above intrinsic estimates. Revenue has contracted by 2.8% YoY and debt‑to‑equity sits near 94%, raising concerns about balance‑sheet resilience. The firm carries no dividend, so income‑oriented investors receive no yield. Nonetheless, the business operates in the defensive beverages sector, which historically cushions earnings during economic slowdowns. The Fear & Greed Index reads “Extreme Greed,” indicating that market sentiment may be overly optimistic.
Given these mixed signals, the near‑term outlook leans cautious while the longer horizon retains a value‑oriented appeal.
Given these mixed signals, the near‑term outlook leans cautious while the longer horizon retains a value‑oriented appeal.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below support and SMA20
- Overbought RSI and bearish MACD
- Decreasing volume and high volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Defensive sector fundamentals
- Negative revenue growth but stable operating margins
- Elevated market sentiment may correct
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Significant discount to DCF fair value
- Low PE indicating potential value upside
- Global brand diversification providing resilience
Key Metrics & Analysis
Financial Health
Revenue Growth-2.80%
Profit Margin6.56%
P/E Ratio1.9
ROE9.94%
ROA4.31%
Debt/Equity93.52
P/B Ratio0.2
Op. Cash FlowCA$5.0B
Free Cash FlowCA$2.1B
Technical Analysis
TrendBullish
RSI81.8
SupportCA$10.29
ResistanceCA$10.88
MA 20CA$10.79
MA 50CA$10.16
MA 200CA$9.80
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair ValueCA$2.42
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.17
Volatility26.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.